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ABSTRACT 
Objective: Anti-HIV activity studies of methanolic extracts of Adansonia digitata L. leaves, root bark and fruit pulp. 
Methods: Methanolic extracts of A. digitata were tested for HIV enzyme inhibitory activity against HIV-1 reverse transcriptase (RT) and HIV-1 protease 
(PR). HIV-1 RT assay was performed using non-radioactive HIV-RT colorimetric ELISA kit while the HIV-1 PR assay was performed using a fluorogenic 
octapeptide substrate, HIV-FRET (fluorescence resonance energy transfer) and a recombinant HIV-1 protease solution (AnaSpec Inc., USA). 
Results: The percentage inhibition of controls and A. digitata leaves, root bark and fruit pulp extracts were calculated relative to uninhibited HIV-1 
RT and PR in 2% DMSO. The results of the HIV-1 RT assay indicated 26.5% inhibition by root bark extract (50 µg/ml) and 12.2% inhibition by leaf 
extract while the fruit pulp extract (100 µg/ml) has shown only 5.9% inhibition as compared to standard Nevirapine (100 nM) 27.5% inhibition. 
In the case of HIV-protease assay, leaf extract and fruit pulp extract (50 µg/ml) has shown quite high inhibition (≥ 50%) to the extent of 75% and 
74% respectively which is very significant. The root bark extract has shown 35% inhibition.  
Conclusion: Methanolic extract of the leaves, root bark and fruit pulp of A. digitata has shown low anti-HIV-1 RT but significant PR activity. HIV-1 
RT activity of root bark extract and HIV-1 PR activity of fruit pulp extract indicates the potential of the plant as an anti-HIV agent.  
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India, with a population of over one billion, is experiencing a rapid 
and extensive spread of HIV. According to the 2012 report, the 
estimated number of people living with HIV/AIDS in India was 2.089 
million in 2011. The adult (15-49 age-group) HIV prevalence at 
national level has continued its steady decline from estimated level 
of 0.41% in 2001 to 0.27% in 2011. But still, India is estimated to 
have the third-highest number of people living with HIV/AIDS, after 
South Africa and Nigeria [1]. 
There are two related but distinct types of HIV: HIV-1 and HIV-2 [2]. 
HIV-1 is the most pathogenic and causes over 99% of HIV infections 
[3]. Various studies carried out in different parts of India highlights 
the fact that HIV-1 subtype C is the most prevalent subtype in India 
[4]. India initiated HIV-prevention activities in the very early stages 
of the epidemic and committed to prevention efforts. The National 
AIDS Control Organization [5] was constituted in 1986 and the 
National AIDS Control Program launched a year later. To enhance 
RandD in this area, NACO identifies and promotes Indian academic 
institutions that conduct epidemiological and operational research 
for the treatment of HIV/AIDS, including research on indigenous 
systems of medicine such as Ayurveda and Siddha. Natural products 
provide a large reservoir for the screening of anti-HIV agents with 
novel structure and antiviral mechanism because of their structural 
diversity. A variety of natural products has been found to inhibit 
unique enzymes and proteins crucial to the life cycle of HIV. The 
most efficient interventions are at the stages of the reverse 
transcription process, virus entry, integration of viral DNA into the 
host genome and protease inhibition [6, 7] However mechanism of 
anti-HIV activities of many more natural products is unknown. In 
India, traditional medicine is used to meet the primary health care 
need and to treat AIDS patients [8, 9]. Screening of plants worldwide 
based on ethnopharmacological data to isolate the active 
constituents from plants for preventing transmission of HIV–AIDS 
patients increases the potential of finding novel phytoconstituents 
present in them [10-13]. 
Many compounds with anti-HIV-1 effect have been screened out from 
natural products and discovered to inhibit HIV at nearly all stages of 
viral life cycle [14]. They include alkaloids, sulphated polysaccharides, 
polyphenolics, flavonoids, coumarins, phenolics, tannins, triterpenes, 
lectins, phloroglucinols, lactones, iridoids, depsidones, O-caffeoyl 
derivatives, lignans, and ribosome inactivating proteins, saponins, 
xanthones, naphthodianthrones, photosensitisers, phospholipids, 
quinines and peptides [15-18].  
Adansonia digitata L. family, Bombaceae, is known by various names 
such as Baobab and Lemonade tree. It is endemic to Africa. In India, 
it grows naturally in Mandu region of Madhya Pradesh. It is very 
common in Andhra Pradesh and also cultivated in Uttar Pradesh, 
Bihar, Tamil Nadu and Maharashtra [19]. It is one of the largest and 
reportedly longest living species (6000 y) of the world [20, 21]. 
A variety of phytochemicals constituents such as terpenoids, 
flavonoids, sterols, vitamins, amino acids, carbohydrates, and lipids 
[21] have been reported from A. digitata. The different plant parts 
are widely used as food, medicine, clothing and shelter. In folk 
medicine it is used as antipyretic, febrifuge, astringent in diarrhoea 
and dysentery, also as a substitute for cinchona in various systems of 
medicine [22]. The pith of the fruit contains high levels of ascorbic 
acid (vitamin C), tartaric acid, and citric acid and is used in 
producing a refreshing drink. Seeds are eaten fresh or dried. They 
can also be ground into a powder and used as a substitute for coffee. 
The leaves are said to be rich in vitamin C, sugars, potassium 
tartrate, and calcium. The leaves are freshly cooked as a vegetable or 
dried and crushed for later use by local people [23, 24]. The leaves 
are used medicinally against fever by reducing sweating and as an 
astringent by tightening mucous membranes thus reducing mucous 
secretions. In West Africa, the leaves and bark are used for treating 
urinary disorders and diarrhoea. Young roots are cooked and eaten 
[24-26]. Antibacterial and anti-Trypanosome activities have also 
been indicated by the plant extracts [27, 28]. Toxicological and 
pharmacological studies such as anti-inflammatory, analgesic, 
antipyretic, antibacterial and antiviral activities of the various plant 
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parts of A. digitata have also been reported [29]. Root bark and leaf 
extract of A. digitata have shown significant antiviral activity against 
Herpes simplex, Sindibis and Poliovirus [30]. This has led to the 
current study to investigate the potential of various plant parts of A. 
digitata to inhibit HIV-1 enzymes. 
MATERIALS AND METHODS 
Plant collection and authentication 
Fresh leaves, fruits and root bark of A. digitata L. were collected 
from Mandu, Madhya Pradesh, India, in the month of September 
2010. The collected plant was authenticated by Dr. Pramod Patil, 
Professor, Department of Botany, M. L. B. Girls Post Graduate 
College, Bhopal, India. Voucher specimen 00919 has been deposited 
in their laboratory for future reference. 
Extraction 
The plant material was washed well with water to separate the 
adhering soil material and dried in the shade. Dried leaves, fruit pulp 
and bark were comminuted to form a coarse powder. Dried 
powdered leaves, fruit pulp and bark (500 g each) were extracted 
with petroleum ether (60-80 °) for 24 h to remove fatty substances. 
Defatted dried marc was further extracted with methanol. All the 
extracts obtained were evaporated to dryness under vacuum in a 
rotary evaporator at 40 °C. All the extracts were subjected to 
preliminary phytochemical screening to detect various plant 
constituents. 
Analytical studies 
Fifty milligrams of the residue extract was dissolved in 5 ml 
methanol in a volumetric flask, filtered and made up the volume up 
to 5 ml for each sample. 
HPTLC was carried out on silica gel 60 F254 precoated aluminium 
plates 0.2 mm thickness, Merck India Limited Mumbai. An 
Applicator from Camag Linomat-5 (Camag Switzerland: 140443) 
was used for band application and photo documentation unit 
(Camag Reprostar-3: 140604) was used for documentation of 
chromatographic fingerprints. The mobile phase used for leaf and 
fruit pulp extract was toluene: ethyl acetate: diethylamine (7:3:0.5), 
whereas for root bark extract it was toluene: ethyl acetate (9:1). The 
HPTLC plates were developed over a distance of 9 cm in a saturated 
development chamber (Twin through chamber 10X10 cm with SS 
lid) and visualized under 254 nm, visible light. After derivatization, 
the plates were again visualized at 254 nm, 366 nm and under 
visible light for all the extracts. After development, plates were 
sprayed with 5% methanolic sulphuric acid followed by heating at 
105 °C for 5-10 min. 
HIV-Reverse transcriptase assay 
The effect of the methanolic extracts of the leaves, root bark and 
fruit pulp of A. digitata was tested by using non-radioactive HIV-
RT colorimetric ELISA kit (Roche Diagnostics, Germany). The 
protocol outlined in the kit was followed, under nuclease free 
conditions by using 2 ng of the enzyme in each well and incubating 
the reaction for 2 h at 37 °C. The negative controls for the assay 
included HIV-1 RT with only lysis buffer, HIV-1 RT with only 
solvent (2% DMSO) in lysis buffer. The blank consisted only 2,2’-
azino-bis (3-ethylbenzo-thiazoline-6-sulphonic acid) abbreviated 
as ABTS.  
The positive control used was nevirapine (Aspen Pharmacare, 
South Africa), which is one of the most common reverse 
transcriptase inhibitors used in clinical practice. The HIV-RT 
inhibition of methanolic extracts was measured as a percentage of 
the inhibition that occurred with HIV-1 RT in the presence of no 
inhibitor in the same solvent (2% DMSO) as the extracts.
HIV-protease assay 
  
The HIV-1 PR assay was performed by using a fluorogenic 
octapeptide substrate, HIV-FRET (1) (Fluorescent resonance energy 
transfer) and a recombinant HIV-1 protease solution (Ana Spec Inc., 
USA). The peptide sequence of HIV-1 FRET (1) is derived from a 
natural processing site for HIV-1 PR and its structure is reported as: 
4-(4-dimethylaminophenylazo)-benzoic acid (DABCYL)-Ser-Gln-
Asn-Tyr-Pro-Ile-Val-Gln-5-[(2-aminoethyl) amino] naphthalene-1 
sulfonic acid (EDANS)]. The procedure for the continuous 
fluorogenic detection of HIV-1 PR was adopted from the method 
reported by Matayoshi et al. [31]. The fluorogenic substrate was 
dissolved in DMSO to 1.3 mM. The stock recombinant HIV-1 
protease solution of 200 ng/µl was diluted to the concentration of 
75 ng/45 µl of freshly prepared assay buffer (100 mM sodium 
acetate, 1 M sodium chloride, 1 mg/ml BSA, 1 mM EDTA and 1 mM 
dithiothreitol, pH 4.7). To the wells of a 96-well black microtiter 
plate, 45 µl of diluted HIV-1 PR (adjusted to a final concentration of 
75 ng/well) and 5 µl of methanolic extract or control were added 
and incubated at 37 °C for 15 min. During this incubation process, 
the stock substrate was diluted to 16 M by assay buffer and pre-
heated to 37 °C. The diluted substrate (50 µl) was added, to initiate 
the reaction of substrate cleavage by HIV-1 PR.  
The microplates were then shaken to 300 rpm for 1 min. and the 
fluorescence intensity was measured kinetically every 30 sec over a 
period of 100 min. at an excitation wavelength of 355 nm and an 
emission wavelength of 460 nm, at 37 °C, using a Fluoroskan Ascent 
FL microplate reader (Thermolab systems). The reaction rates were 
determined by the gradient of the initial linear portions (first 5-10 
min) of the plot of Relative fluorescence intensity (RFI) as a function 
of time. Negative controls were HIV-1 PR with only assay buffer, 
HIV-1 PR enzyme with DMSO (2%) in assay buffer and substrate 
alone. Positive controls were taken as ritonavir and pepstatin at a 
final concentration of 0.2 µM (Bachem, Switzerland). The percentage 
inhibition of HIV-1 PR was calculated as a percentage of control with 
only solvent (2% DMSO).  
RESULTS 
Extractive values and preliminary phytochemical screening 
The leaves (ASLE), root bark (ASBE), fruit pulp (FPE) of A. digitata 
afforded methanolic extract in the percent yield of 3%, 2.3% and 
1.4% respectively. Preliminary phytochemical screening of all the 
extracts revealed the presence of flavonoids, steroids, tannins, 
glycosides and amino acids. 
High performance thin layer chromatography 
High performance thin layer chromatographic study of the 
methanolic extract of leaf (ASLE) in the solvent system, toluene: 
ethyl acetate: diethyl amine (7:3:0.5) revealed five spots with Rf 
values 0.10 (yellow), 0.64 (yellowish green), 0.82 (black), 0.84 
(green) and 0.90 (green) when observed under visible light while 
fruit pulp extract (FPE) in the same solvent system showed four 
spots with Rf value 0.34 (light blue), 0.64 (faint), 0.71 (light blue), 
0.84 (blue) when observed at 366 nm. Methanolic extract of the bark 
(ASBE) in the solvent system, toluene: ethyl acetate (9:1) revealed 
one major and seven minor spots with Rf values 0.12 (white), 0.16 
(red), 0.26 (sky blue), 0.28 (red), 0.37 (blue), 0.50 (red), 0.60 (blue), 
0.66 (red) when observed at 366 nm as reported by Sharma and 
Rangari [32]. 
HIV-Reverse transcriptase assay 
The percentage inhibition of controls and A. digitata leaves, root 
bark and fruit pulp extracts were calculated relative to 
uninhibited HIV-1 RT in 2% DMSO (fig. 1). The results of the 
HIV-1 RT assay indicated 26.5% inhibition by root bark extract 
(50 µg/ml) and 12.2% inhibition by leaf extract (50 µg/ml) while 
the fruit pulp extract (100 µg/ml) has shown only 5.9 % 
inhibition as compared to standard nevirapine (100 nM) 27.5 % 
inhibition. 
HIV-protease assay 
The percentage inhibition of controls and A. digitata leaves, root 
bark and fruit pulp extracts were calculated relative to uninhibited 
HIV-1 PR in 2% DMSO (fig. 2). The leaf and fruit pulp extract (50 
µg/ml) have shown quite high inhibition (≥ 50%) to the extent of 
75% and 74% respectively which is very significant. Since BSA was 
already present in the protease assay buffer at 0.1%, tannin 
adsorption would already have taken place. 
Rangari et al. 




Fig. 1: HIV-1 RT inhibition by leaves, root bark and fruit pulp 
extract of A. digitata. Data are expressed as means±SEM of at 
least three independent measurements. The RT inhibition of all 
methanolic extracts are the mean of three separate 
experiments 
ASLE: A. digitata leaves extract, ASBE: A. digitata root bark extract, 
FPE: A. digitata fruit pulp extract. 
 
 
Fig. 2: HIV-1 PR inhibition by leaves, root bark and fruit pulp 
extract of A. digitata. Data are expressed as means±SEM of at 
least three independent measurements. The PR inhibition of all 
methanolic extracts are the mean of three separate 
experiments 
ASLE: A. digitata leaves extract, ASBE: A. digitata root bark extract, 
FPE: A. digitata fruit pulp extract. 
 
DISCUSSION 
The results depicted in fig. 1, showed the significant inhibition of 
HIV-1 RT by the root bark extract while the leaf and fruit pulp 
extract showed very less inhibition. This significant inhibition of HIV-
1 RT by root bark extract seems to be due to the presence of various 
flavonoid glycosides reported from the roots of A. digitata L [21, 33-
34]. This HIV-1 RT inhibitory effect of such flavonoids has also 
reported in Chamaesyce hyssopfolia [35] and Vitex negundo L [36]. 
The leaves and fruit pulp extract showed the significant HIV-1 PR 
inhibition (75 % and 74% respectively) as indicated in fig. 2. We 
would like to mention here that the results obtained in the cases of 
leaves and fruit pulp extracts does not seem to be reliable due to 
high background fluorescence. However, these significant results 
can be ascribed to the presence of the various proanthocyanidin 
compound reported in the leaves and the epicatechin compounds 
reported from the fruit pulp of A. digitata [37]. Such potential HIV-1 
PR inhibitory activities have been reported in a number of 
structurally similar flavonoids and tannins [38-40]. 
CONCLUSION 
The results obtained from this experimental work indicated that the 
flavonoids, proanthocynins and catechins present in the root bark, 
leaves and fruit pulp extracts of A. digitata have very strong 
potential to inhibit HIV-1 RT and PR enzymes. Further 
phytochemical and anti-HIV activity studies may provide important 
leads from A. digitata for the development of anti-HIV agent. 
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